THYMOSIN-BETA 4

Thymosin Beta-4 Peptide – Research Grade

Thymosin Beta-4 is a synthetic peptide composed of 43 amino acids and is widely studied in controlled laboratory environments for its role in cellular migration, cytoskeletal organization, and tissue-related signaling pathways. This peptide is supplied strictly for scientific and experimental research purposes and is not intended for clinical, diagnostic, or therapeutic use.

Produced using advanced solid-phase peptide synthesis (SPPS), Thymosin Beta-4 is purified to a high degree to ensure molecular consistency and reproducibility across research applications. Each batch undergoes rigorous analytical verification through High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm identity, purity, and structural integrity.

Research Characteristics

• Peptide Name: Thymosin Beta-4 (Tβ4)
• Amino Acid Length: 43 residues
• Synthesis Method: Solid-phase peptide synthesis (SPPS)
• Purity: ≥ 99% (HPLC verified)
• Form: Lyophilized powder
• Stability: Stable under recommended laboratory storage conditions

Experimental Applications

Thymosin Beta-4 is commonly utilized in in-vitro and pre-clinical research models exploring actin regulation, cellular repair mechanisms, angiogenesis-related signaling, and tissue regeneration pathways. Its application is strictly limited to controlled laboratory research settings where analytical accuracy and experimental consistency are required.

Quality & Documentation

Every batch of Thymosin Beta-4 is subject to comprehensive quality control protocols to ensure purity, consistency, and molecular accuracy prior to release. Certificates of Analysis (COA) are provided with each order to support research documentation, traceability, and validation requirements.

Important Notice: This product is intended for laboratory research use only and is not for human or animal consumption. It is not intended for diagnostic, therapeutic, or clinical applications of any kind.